The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

NEW YORK — MDxHealth on Wednesday posted a 22 percent year-over-year increase in its first quarter revenues, topping Wall Street's consensus estimate. For the three-month period ended March 31, ...

EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke patients in the UK, Europe, and US.

Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...

Last week, readers were most interested in a story about Castle Biosciences' buy of Previse and its plans to expand its gastrointestinal diagnostic test offerings.

The home-collected vaginal samples can be shipped to CLIA-certified labs for testing on the Roche Cobas system.

NEW YORK – Although it had multiple products with regulatory clearance and technology that had been validated by outside users, Accelerate Diagnostics' inability to attract buyers for its instruments ...

Note: This story has been updated with comments from a conference call to discuss the firm's financial results. NEW YORK – Siemens Healthineers said Wednesday that it expects tariffs implemented by ...

The agreement enables rapid diagnostic test manufacturing in the Africa region and will initially focus on HIV testing.